Zou Liang, Yu Di, Wang Qingfeng, Liu Hui, Cun Yueshuang, Li Yaping, Qi Jirong, Mo Xuming, Peng Wei, Shu Yaqin
Department of Cardiothoracic Surgery, Children's Hospital of Nanjing Medical University, Jiangdong South No. 8 Road, Nanjing, 210008, China.
BMC Cardiovasc Disord. 2025 Mar 17;25(1):191. doi: 10.1186/s12872-025-04635-6.
Venoarterial extracorporeal membrane oxygenation (VA ECMO) is a critical therapeutic intervention that is commonly used in the management of paediatric patients with congenital heart disease (CHD). This procedure can be initiated either inraoperatively or postoperatively. However, few studies have reported data on the comparative clinical outcomes associated with different timings of VA ECMO initiation. In this study, patient characteristics and clinical outcomes between intraoperative and postoperative VA ECMO in infants undergoing cardiac surgery were compared and predictors of ECMO initiation were determined, which may improve clinical outcomes.
A total of 47 infants who received postcardiotomy VA ECMO support from September 2019 to December 2023 were included in this retrospective, single-centre observational study. Patients who received VA ECMO support in the operating room (intraoperative, n = 27) were compared with those who received it in the intensive care unit (postoperative, n = 20). Kaplan‒Meier curves were further analysed for survival and perioperative factors were evaluated to predict VA ECMO initiation.
Survival rates were greater in the intraoperative group (70.37% vs. 25%; P = 0.002), with a reduced risk of mortality (HR: 2.84; 95% CI: 1.23-6.55). The intraoperative group also had a higher ECMO weaning rate (88.89% vs. 45%, P < 0.001) and shorter VA ECMO duration (5.00 ± 1.80 days vs. 7.50 ± 2.76 days; P < 0.001). Continuous renal replacement therapy (CRRT) was needed in 100% of postoperative patients versus 70.40% of intraoperative patients (P = 0.014). The combination of preoperative lactate ≥ 6.495 mmol/L and cardiopulmonary bypass (CPB) time ≥ 138 min predicted the need for intraoperative VA ECMO [AUC (area under the curve): 0.893 (95% CI: 0.805-0.980, P < 0.001)].
Compared with postoperative VA ECMO, the use of Intraoperative VA ECMO might improve clinical outcomes in infants undergoing cardiac surgery, highlighting the potential benefits of early intervention. The significant predictive value of the CPB time and preoperative lactate level may inform future clinical practices regarding the timing of ECMO initiation in paediatric patients postcardiotomy.
静脉-动脉体外膜肺氧合(VA ECMO)是一种关键的治疗干预措施,常用于先天性心脏病(CHD)小儿患者的管理。该操作可在术中或术后启动。然而,很少有研究报告不同VA ECMO启动时机相关的比较临床结果数据。在本研究中,比较了心脏手术婴儿术中与术后VA ECMO的患者特征和临床结果,并确定了ECMO启动的预测因素,这可能会改善临床结果。
本回顾性单中心观察性研究纳入了2019年9月至2023年12月接受心脏术后VA ECMO支持的47例婴儿。将在手术室接受VA ECMO支持的患者(术中,n = 27)与在重症监护病房接受支持的患者(术后,n = 20)进行比较。进一步分析Kaplan-Meier曲线以评估生存率,并评估围手术期因素以预测VA ECMO的启动。
术中组的生存率更高(70.37%对25%;P = 0.002),死亡风险降低(HR:2.84;95%CI:1.23 - 6.55)。术中组的ECMO撤机率也更高(88.89%对45%,P < 0.001),VA ECMO持续时间更短(5.00 ± 1.80天对7.50 ± 2.76天;P < 0.001)。100%的术后患者需要持续肾脏替代治疗(CRRT),而术中患者为70.40%(P = 0.014)。术前乳酸≥6.495 mmol/L和体外循环(CPB)时间≥138分钟的组合可预测术中需要VA ECMO [曲线下面积(AUC):0.893(95%CI:0.805 - 0.980,P < 0.001)]。
与术后VA ECMO相比,术中使用VA ECMO可能会改善心脏手术婴儿的临床结果,突出了早期干预的潜在益处。CPB时间和术前乳酸水平的显著预测价值可能为小儿心脏术后患者ECMO启动时机的未来临床实践提供参考。